Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
related investing news"Upon information and belief, Pfizer knowingly uses GSK's claimed inventions in Abrysvo without permission," GSK wrote in a scathing complaint filed in federal court in Delaware.
A Pfizer spokesperson said it is "confident in its intellectual property position and will strongly defend its right to bring its innovative" RSV shot to patients. Both vaccines were approved by the U.S. Food and Drug Administration in May for use in adults 60 and above. They are the first shots approved to prevent RSV, a common respiratory infection that usually causes mild, cold-like symptoms, but more severe cases in older adults and children.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Walgreens is now offering RSV vaccines for older adultsThis is the first RSV season in which older adults have the option to get vaccinated against the virus.
Baca lebih lajut »
Vaccines for flu and RSV now available ahead of fall virus season | CNNWith the fall respiratory virus season just around the corner, major US pharmacy chains have begun rolling out flu and RSV vaccine appointments.
Baca lebih lajut »
US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapiesThe U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of long COVID.
Baca lebih lajut »
Pfizer mulls cost cuts on volatile COVID products demandPfizer will launch a cost-cutting program if demand for its COVID-19 products keeps underperforming expectations this fall, the U.S. drugmaker said on Tuesday, after quarterly sales for the vaccine and pill fell short of Wall Street targets.
Baca lebih lajut »
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease ShortfallPfizer’s second-quarter revenue fell short of analysts’ estimates, but the company is looking at new drug launches and deal-making to help drive revenue via WSJ
Baca lebih lajut »
Updated Covid boosters could be authorized by end of month, Pfizer saysThe FDA could authorize Pfizer's updated Covid boosters by the end of August, Pfizer CEO Albert Bourla said during an investor call.
Baca lebih lajut »